Financial News · Live Terminal

Page 62 of 307

HC Wainwright Downgrades Fulcrum Therapeutics to Neutral From Buy, Adjusts PT to $3 From $25

Fulcrum Therapeutics (FULC) has an average rating of hold and mean price target of $9.22, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Financial News · Live Terminal

HC Wainwright Downgrades Fulcrum Therapeutics to Neutral From Buy, Adjusts PT to $3 From $25

Axis Capital Starts Clean Max Enviro Energy Solutions at Buy with INR1,375 Price Target

Choice Equity Upgrades Fiem Industries to Buy from Add; Price Target is INR2,700

Leerink Partners Downgrades Fulcrum Therapeutics to Market Perform From Outperform, Adjusts PT to $4 From $24

Jefferies Downgrades StandardAero to Hold From Buy, Adjusts Price Target to $30 From $34

Evercore ISI Upgrades Guardant Health to Outperform From In Line, Adjusts PT to $160 From $95

Avendus Spark Upgrades Siemens to Add from Reduce; Price Target is INR4,214

Avendus Spark Upgrades Cummins India to Add from Reduce; Price Target is INR6,256

Forsyth Barr Downgrades Tourism Holdings to Neutral from Outperform; Price Target is NZ$3.10

Leerink Partners Initiates X4 Pharmaceuticals at Outperform With $12 Price Target

UBS Initiates Seven Hills Realty Trust at Buy With $10 Price Target

Oppenheimer Initiates Odyssey Therapeutics at Outperform With $40 Price Target

Cantor Fitzgerald Initiates Odyssey Therapeutics at Overweight

Truist Downgrades Taylor Morrison Home to Hold From Buy Following Deal Announcement, Keeps $72.50 Price Target

Choice Equity Downgrades Concord Biotech to Reduce from Add; Price Target is INR1,045

JM Financial Starts Bluestone Jewellery and Lifestyle at Buy with INR650 Price Target

Loop Capital Upgrades Hewlett Packard Enterprise to Buy From Hold, Adjusts PT to $75 From $23

Canaccord Genuity Initiates Enhanced Group at Buy With $6 Price Target

TD Cowen Initiates Odyssey Therapeutics at Buy

Needham Initiates VeraDermics at Buy With $136 Price Target

HC Wainwright Downgrades Fulcrum Therapeutics to Neutral From Buy, Adjusts PT to $3 From $25

Axis Capital Starts Clean Max Enviro Energy Solutions at Buy with INR1,375 Price Target

Choice Equity Upgrades Fiem Industries to Buy from Add; Price Target is INR2,700

Leerink Partners Downgrades Fulcrum Therapeutics to Market Perform From Outperform, Adjusts PT to $4 From $24

Jefferies Downgrades StandardAero to Hold From Buy, Adjusts Price Target to $30 From $34

Evercore ISI Upgrades Guardant Health to Outperform From In Line, Adjusts PT to $160 From $95

Avendus Spark Upgrades Siemens to Add from Reduce; Price Target is INR4,214

Avendus Spark Upgrades Cummins India to Add from Reduce; Price Target is INR6,256

Forsyth Barr Downgrades Tourism Holdings to Neutral from Outperform; Price Target is NZ$3.10

Leerink Partners Initiates X4 Pharmaceuticals at Outperform With $12 Price Target

UBS Initiates Seven Hills Realty Trust at Buy With $10 Price Target

Oppenheimer Initiates Odyssey Therapeutics at Outperform With $40 Price Target

Cantor Fitzgerald Initiates Odyssey Therapeutics at Overweight

Truist Downgrades Taylor Morrison Home to Hold From Buy Following Deal Announcement, Keeps $72.50 Price Target

Choice Equity Downgrades Concord Biotech to Reduce from Add; Price Target is INR1,045

JM Financial Starts Bluestone Jewellery and Lifestyle at Buy with INR650 Price Target

Loop Capital Upgrades Hewlett Packard Enterprise to Buy From Hold, Adjusts PT to $75 From $23

Canaccord Genuity Initiates Enhanced Group at Buy With $6 Price Target

TD Cowen Initiates Odyssey Therapeutics at Buy

Needham Initiates VeraDermics at Buy With $136 Price Target